Bio-Connect
Human TNFsR I PicoKine ELISA Kit Standard Curve
Human TNFsR I PicoKine ELISA Kit Standard Curve
Human TNFsR I PicoKine ELISA Kit Standard Curve

Human TNFsR I PicoKine ELISA Kit

EK0528
Boster Bio
ReactivityHuman
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human TNFsR I PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    7.8 pg/ml - 500 pg/ml
  • Assay Sensitivity
    <1 pg/ml
  • Assay Time
    15-20
  • Certification
    Research Use Only
  • Scientific Description
    Human TNFsR I ELISA Kit PicoKine® (96 Tests). Quantitate Human TNFRSF1A in cell culture supernatants, serum, plasma ( heparin, EDTA, citrate) and urine. Sensitivity: 1pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity
    Human
  • Reactivity Supplier
    Human TNFsR I
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Pedraza A, Salas MQ, Rodríguez-Lobato LG, et al. Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation. Transplant Cell Ther. 2024,30(2):187.e1-187.e12. doi: 10.1016/j.jtct.2023.11.016
    Read this paper
  • Mir E, Palomo M, Rovira M, et al. Endothelial damage is aggravated in acute GvHD and could predict its development. Bone Marrow Transplant. 2017,52(9):1317-1325. doi: 10.1038/bmt.2017.121
    Read this paper
  • Li J, Huang M, Shen X. The association of oxidative stress and pro-inflammatory cytokines in diabetic patients with hyperglycemic crisis. J Diabetes Complications. 2014,28(5):662-6. doi: 10.1016/j.jdiacomp.2014.06.008
    Read this paper